Dr. Mahesh Kumar Seth: Associate Professor & Research Track Faculty

Dr. Mahesh Kumar Seth

 

NameDr. Mahesh Kumar Seth
DesignationAssociate Professor & Research Track Faculty
QualificationMSc, MBA, PhD
Total Years of Work Experience> 16 Years
Total Years of Work Experience> 4 years
Total Years of Work Experience–
Email ID[email protected]
Teaching Interests–
Research InterestsRespiratory, Inflammatory and Cardiovascular diseases
Recent Publications1. Association of leptin with polycystic ovary syndrome: A systematic review and meta analysis”
Mahesh Kumar Seth1#, Sarthak Gulati1#, , Shreya Gulati3, Amit Kumar4*, Dimple Rawat1, Aradhana1, Rohini Sehgal5, Rinchen Zangmo5, Vivek Dixit6, Premlata1, Arti Gulati1 May 2021, The Journal of Obstetrics and Gynecology2. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice. Euro J Pharmacol . 2020 Aug 1;886:173391. doi: 10.1016/j.ejphar.2020.173391. Tandon R, Soni A, Singh RK, Sodhi R, Seth MK, Sinha S, Sahdev S, Dhage G, Das B, Dastidar SG, Shirumalla RK, Yonesu K, Marumoto S, Nagayama T.3. 1. Effects of a novel ACE inhibitor 3-(3-Thienyl)-L-alanyl-Ornithyl-Proline on endothelial vasodilation and hepatotoxicity in L-NAME induced hypertension in rat. Mahesh Kumar Seth, M Ejaz Hussain, Santosh Pasha (Drug Design, Development and Therapy 2016:10 1533–1542).

4. Sulfur-containing angiotensin-converting enzyme inhibitor 3-thienylalanine-ornithyl-proline activates endothelial function and expression of genes involved in Renin-Angiotensin system. Chaudhary S*, Seth MK*, Vats ID, Kumar K, Biswas P, Karar J, Hussain ME, Pasha MA, Pasha S. J Cardiovasc Pharmacol. 2013 Apr;61(4):311-7. (* Equally Contribution)

5. Pharmacological properties of a novel PI3Kd inhibitor DS-1515. Kenichi Wakita, Kumiko Koyama, Shintaro Nakayama, Yumi Nishiya, Puneet Chopra, Mahesha Seth, Pooja Chabbra, Punit Srivastava, Ankur Kumar,Manish Diwan, Kiyoshi Morimoto, Masakatsu Suzuki. European Respiratory Journal 2018 52: PA1054; DOI: 10.1183/13993003.

6.Pharmacology of a Novel,Orally Active PDE4 lnhibitor SunandGa .D astidar a Abhjit Ray a Rajkumar Shirumalla a Deepa Rajagopal’ Shiwani Chaudhary a Kamna Nanda a Pawan Sharma a Mahesh Kumar Seth” Sarala Balachandran b Nidhi Gupta b Venkat Palle Department of Pharmacology a b Department of Medicinal Chemistry Ranbaxy Research Laboratories, Gurgaon, India.( Journal of Pharmacology; 2009)

7. Impact of Obesity on Live Birth among Women Undergoing IVF/ICSI: A Meta-Analysis Sarthak Gulati1, Dimple Rawat2, Shreya Gulati3, Rinchen Zangmo4, Arti Gulati5, Mahesh Kumar Seth 6 Aradhana Kumari7, and Amit Kumar8
Department of Orthopedics, J.J.M Medical College, Davanagere, Karnataka1 Clinical Epidemiology Unit, All India Institute of Medical Sciences, New Delhi2,5,6,7 Dr. Ram Manohar Lohia Hospital, New Delhi3
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi4 Department of Neurology, All India Institute of Medical Sciences, New Delhi-8 (HJHW: 2021, 12(3), 344-353).

8. Transmission and case fatality rate associated with COVID-19 in Asian countries as per Global hunger index score
Dimple Rawat, Sarthak Gulati, Shreya Gulati, Anshu Sharma, Arti Gulati, Vineet Kumar Kamal, Mahesh Kumar Seth, Amit Kumar
JIMA, VOL 118, NO 12, DECEMBER 2020

Conferences, Seminars & Workshops 25

Faculty Members

Dr. Mahesh Kumar Seth

Associate Professor & Research Track Faculty

About

–

Qualification:

  • MSc
  • MBA
  • PhD

Total Years of Work Experience:

  • >16 Years

Email ID:

Teaching Interests:

  • Environment Engineering 

Research Interests:

  • Respiratory
  • Inflammatory
  • Cardiovascular diseases

No of Recent Publications:

  • 08

No of Conferences, Seminars & Workshops:

  • 25